<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37040829</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-2990</ISSN><JournalIssue CitedMedium="Internet"><Volume>366</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>The American journal of the medical sciences</Title><ISOAbbreviation>Am J Med Sci</ISOAbbreviation></Journal><ArticleTitle>Echocardiographic manifestations during the first 3 months after an episode of COVID-19 and their relationship with disease severity and persistence of symptoms.</ArticleTitle><Pagination><StartPage>32</StartPage><EndPage>37</EndPage><MedlinePgn>32-37</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amjms.2023.04.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0002-9629(23)01127-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">Cardiovascular manifestations in patients with COVID-19 are associated with dire outcomes. Long COVID syndrome is the persistence of symptoms after acute disease and is found in up to 40% of subjects. There is little information regarding subacute echocardiographic manifestations after COVID-19, and no study has included a Mexican mestizo population.</AbstractText><AbstractText Label="METHODS">This cross-sectional study included subjects older than 18 with an episode of COVID-19 in the last 3 months. Those with previously known cardiovascular disease were excluded. The patient&#xb4;s medical history and COVID-19 information were obtained from clinical charts. We performed a transthoracic echocardiogram in every subject and determined left ventricular (LV) index mass, LV ejection fraction (LVEF), left ventricular global longitudinal strain (LV GLS), right ventricular (RV) GLS, and tricuspid annular plane systolic excursion (TAPSE). A descriptive and comparative analysis was performed based on symptom severity and persistence.</AbstractText><AbstractText Label="RESULTS">One hundred subjects were included; 63% were classified with mild and 37% with moderate to severe COVID-19. The median of LVEF was 60% (55-60), LV GLS and RV GLS was impaired in 34% and 74% of patients, respectively. Patients with moderate to severe disease had significantly lower LVEF (Mean Difference: -3.3), TAPSE (mean difference: -1.8), and higher (worse) LV GLS (Mean Difference: 2.5) and RV GLS (mean difference: 2.9). Persistent symptoms were associated with lower TAPSE and higher RVGLS.</AbstractText><AbstractText Label="CONCLUSIONS">Patients who recover from COVID-19 have a high prevalence of subtle RV and LV dysfunction using GLS analysis. A moderate to severe episode was associated with worse RV and LV function measured by RV GLS, TAPSE, and LV GLS. Subjects with persistent symptoms had worse RVGLS and TAPSE.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vera-Pineda</LastName><ForeName>Raymundo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiology Service, Hospital Universitario, Universidad Aut&#xf3;noma de Nuevo Le&#xf3;n, Monterrey, Nuevo Le&#xf3;n, Mexico; Division of Interventional Cardiology, Hospital Universitario, Universidad Aut&#xf3;noma de Nuevo Le&#xf3;n, Monterrey, Nuevo Le&#xf3;n, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrizales-Sep&#xfa;lveda</LastName><ForeName>Edgar Francisco</ForeName><Initials>EF</Initials><AffiliationInfo><Affiliation>Cardiology Service, Hospital Universitario, Universidad Aut&#xf3;noma de Nuevo Le&#xf3;n, Monterrey, Nuevo Le&#xf3;n, Mexico; Heart Failure Unit, Hospital Universitario, Universidad Aut&#xf3;noma de Nuevo Le&#xf3;n, Monterrey, Nuevo Le&#xf3;n, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales-Rend&#xf3;n</LastName><ForeName>Eliu Jefte</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Cardiology Service, Hospital Universitario, Universidad Aut&#xf3;noma de Nuevo Le&#xf3;n, Monterrey, Nuevo Le&#xf3;n, Mexico; Division of Interventional Cardiology, Hospital Universitario, Universidad Aut&#xf3;noma de Nuevo Le&#xf3;n, Monterrey, Nuevo Le&#xf3;n, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ordaz-Far&#xed;as</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiology Service, Hospital Universitario, Universidad Aut&#xf3;noma de Nuevo Le&#xf3;n, Monterrey, Nuevo Le&#xf3;n, Mexico; Echocardiography Laboratory, Hospital Universitario, Universidad Aut&#xf3;noma de Nuevo Le&#xf3;n, Monterrey, Nuevo Le&#xf3;n, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sol&#xed;s</LastName><ForeName>Jos&#xe9; Gabriel</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Cardiology Service, Hospital Universitario, Universidad Aut&#xf3;noma de Nuevo Le&#xf3;n, Monterrey, Nuevo Le&#xf3;n, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benavides-Gonz&#xe1;lez</LastName><ForeName>Mario Alberto</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Cardiology Service, Hospital Universitario, Universidad Aut&#xf3;noma de Nuevo Le&#xf3;n, Monterrey, Nuevo Le&#xf3;n, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flores-Ram&#xed;rez</LastName><ForeName>Ramiro</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiology Service, Hospital Universitario, Universidad Aut&#xf3;noma de Nuevo Le&#xf3;n, Monterrey, Nuevo Le&#xf3;n, Mexico; Echocardiography Laboratory, Hospital Universitario, Universidad Aut&#xf3;noma de Nuevo Le&#xf3;n, Monterrey, Nuevo Le&#xf3;n, Mexico. Electronic address: secahu2021@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Med Sci</MedlineTA><NlmUniqueID>0370506</NlmUniqueID><ISSNLinking>0002-9629</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="N">Ventricular Function, Left</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062072" MajorTopicYN="N">Patient Acuity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Echocardiography</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Myocardial Dysfunction</Keyword><Keyword MajorTopicYN="N">Right ventricular longitudinal strain</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest No conflict of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>19</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37040829</ArticleId><ArticleId IdType="pmc">PMC10082966</ArticleId><ArticleId IdType="doi">10.1016/j.amjms.2023.04.002</ArticleId><ArticleId IdType="pii">S0002-9629(23)01127-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Organization WH. COVID-19 weekly epidemiological update. 2022</Citation></Reference><Reference><Citation>Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72&#xa0;314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020</Citation><ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Kremer S., Merdji H. Neurologic features in severe SARS-CoV-2 infection. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedaghat Z., Karimi N. Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci: Off J Neurosurgical Soc Australasia. 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158817</ArticleId><ArticleId IdType="pubmed">32312628</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxley T.J., Mocco J., Majidi S., Kellner C.P. Large-vessel stroke as a presenting feature of Covid-19 in the young. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7207073</ArticleId><ArticleId IdType="pubmed">32343504</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J., Han B., Wang J. COVID-19: gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7130192</ArticleId><ArticleId IdType="pubmed">32142785</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikdeli B., Madhavan M.V., Jimenez D., et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol. 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164881</ArticleId><ArticleId IdType="pubmed">32311448</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhmerov A., Marban E. COVID-19 and the heart. Circ Res. 2020;126</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7188058</ArticleId><ArticleId IdType="pubmed">32252591</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Q., Yang K. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. 2020:1&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7080116</ArticleId><ArticleId IdType="pubmed">32125452</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054&#x2013;1062.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T., Fan Y., Chen M., et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) JAMA cardiology. 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7101506</ArticleId><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y.Y., Ma Y.T. COVID-19 and the cardiovascular system. 2020.</Citation></Reference><Reference><Citation>Shi S., Qin M., Shen B., et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA cardiology. 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Young K.A., Krishna H., Jain V., et al. Serial left and right ventricular strain analysis in patients recovered from COVID-19. J Am Soc Echocardiogr. 2022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9232260</ArticleId><ArticleId IdType="pubmed">35760277</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan S., Kunal S., Shah B., et al. Left ventricular global longitudinal strain in COVID-19 recovered patients. Echocardiography. 2021;38:1722&#x2013;1730.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8653213</ArticleId><ArticleId IdType="pubmed">34555203</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. (Accessed 9/08/2022, at https://www.covid19treatmentguidelines.nih.gov/.)</Citation></Reference><Reference><Citation>Mitchell C., Rahko P.S., Blauwet L.A., et al. Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr. 2019;32:1&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">30282592</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagueh S.F., Smiseth O.A., Appleton C.P., et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29:277&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pubmed">27037982</ArticleId></ArticleIdList></Reference><Reference><Citation>Szekely Y., Lichter Y., Taieb P., et al. The spectrum of cardiac manifestations in coronavirus disease 2019 (COVID-19) - a systematic echocardiographic study. Circulation.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7382541</ArticleId><ArticleId IdType="pubmed">32469253</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrizales-Sep&#xfa;lveda E.F., Vera-Pineda R., Flores-Ram&#xed;rez R., et al. Echocardiographic manifestations in COVID-19: a review. Heart Lung Circ. 2021;30:1117&#x2013;1129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7894123</ArticleId><ArticleId IdType="pubmed">33715970</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Li H., Zhu S., et al. Prognostic value of right ventricular longitudinal strain in patients with COVID-19. JACC: Cardiovascular Imaging. 2020:3423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7195441</ArticleId><ArticleId IdType="pubmed">32654963</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker R.C. COVID-19 update: covid-19-associated coagulopathy. J Thromb Thrombolysis. 2020;50:54&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7225095</ArticleId><ArticleId IdType="pubmed">32415579</ArticleId></ArticleIdList></Reference><Reference><Citation>Bompard F., Monnier H., Saab I., et al. Pulmonary embolism in patients with Covid-19 pneumonia. Eur Respir J. 2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236820</ArticleId><ArticleId IdType="pubmed">32398297</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global prevalence of post COVID-19 condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Tudoran C., Tudoran M., Pop G.N., et al. Associations between the severity of the post-acute COVID-19 syndrome and echocardiographic abnormalities in previously healthy outpatients following infection with SARS-CoV-2. Biology. 2021;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8226755</ArticleId><ArticleId IdType="pubmed">34073342</ArticleId></ArticleIdList></Reference><Reference><Citation>Tudoran C., Tudoran M., Cut T.G., et al. Evolution of echocardiographic abnormalities identified in previously healthy individuals recovering from COVID-19. J Pers Med. 2022;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8778114</ArticleId><ArticleId IdType="pubmed">35055360</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassen M.C.H., Skaarup K.G., Lind J.N., et al. Recovery of cardiac function following COVID-19 - ECHOVID-19: a prospective longitudinal cohort study. Eur J Heart Fail. 2021;23:1903&#x2013;1912.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8652600</ArticleId><ArticleId IdType="pubmed">34514713</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>